The molecular basis of signal-dependent transcriptional activation has been extensively studied in macrophage polarization, but our understanding remains limited regarding the molecular determinants of repression. Here we show that IL-4-activated STAT6 transcription factor is required for the direct transcriptional repression of a large number of genes during in vitro and in vivo alternative macrophage polarization. Repression results in decreased lineage-determining transcription factor, p300, and RNA polymerase II binding followed by reduced enhancer RNA expression, H3K27 acetylation, and chromatin accessibility. The repressor function of STAT6 is HDAC3 dependent on a subset of IL-4-repressed genes. In addition, STAT6-repressed enhancers show extensive overlap with the NF-kB p65 cistrome and exhibit decreased responsiveness to lipopolysaccharide after IL-4 stimulus on a subset of genes. As a consequence, macrophages exhibit diminished inflammasome activation, decreased IL-1b production, and pyroptosis. Thus, the IL-4-STAT6 signaling pathway establishes an alternative polarization-specific epigenenomic signature resulting in dampened macrophage responsiveness to inflammatory stimuli.
In Brief
The molecular bases of repressive transcriptional mechanisms contributing to macrophage polarization are not well understood. Czimmerer et al. show that in alternatively polarized macrophages, IL-4-activated STAT6 represses a large set of enhancers modulating the transcriptional program. STAT6-repressed enhancers are characterized by reduced chromatin accessibility, eRNA expression, LDTF, and p300 binding. IL-4-STAT6-mediated repression limits the inflammatory responsiveness including inflammasome activation, IL-1b production, and pyroptosis. Thus, the IL4-STAT6 pathway establishes an epigenomic signature to selectively repress the macrophage inflammation program.
SUMMARY
The molecular basis of signal-dependent transcriptional activation has been extensively studied in macrophage polarization, but our understanding remains limited regarding the molecular determinants of repression. Here we show that IL-4-activated STAT6 transcription factor is required for the direct transcriptional repression of a large number of genes during in vitro and in vivo alternative macrophage polarization. Repression results in decreased lineage-determining transcription factor, p300, and RNA polymerase II binding followed by reduced enhancer RNA expression, H3K27 acetylation, and chromatin accessibility. The repressor function of STAT6 is HDAC3 dependent on a subset of IL-4-repressed genes. In addition, STAT6-repressed enhancers show extensive overlap with the NF-kB p65 cistrome and exhibit decreased responsiveness to lipopolysaccharide after IL-4 stimulus on a subset of genes. As a consequence, macrophages exhibit diminished inflammasome activation, decreased IL-1b production, and pyroptosis. Thus, the IL-4-STAT6 signaling pathway establishes an alternative polarization-specific epigenenomic signature resulting in dampened macrophage responsiveness to inflammatory stimuli.
INTRODUCTION
Macrophage plasticity is ensured by dynamic and partially reversible responsiveness to pathogen-derived molecules as well as the cytokine and lipid microenvironment. The two wellcharacterized extreme functional outcomes of macrophage polarization are T helper 1 (Th1) cell-type cytokine interferongamma (IFN-g)-induced classical or M(INF-g)-type polarization with enhanced bactericidal capacity and Th2 cell-type cytokine interleukin-4 (IL-4)-induced alternative or M(IL-4)-type polarization with anti-inflammatory properties, but complex molecular cues can generate an entire spectrum of different activation states (Gordon and Martinez, 2010; Murray et al., 2014) .
The major determinant of macrophage plasticity is their specific transcriptional program dictated primarily by lineage-determining transcription factors (LDTFs) including ETS-domain transcription factor PU.1, CCAAT/enhancer binding proteins (C/EBPs), activator protein 1 (AP-1), or Runt-related transcription factor 1 (RUNX1) as well as extracellular signal-dependent transcription factors (SDTFs) including LPS-activated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) or AP-1, IFN-g-activated signal transducer and activator of transcription 1 (STAT1), or IL-4-and IL-13-activated STAT6; for a review see Glass and Natoli (2016) . Despite the fact that polarization signals repress large sets of genes, the repressive activity of polarization-specific transcription factors has not been studied in detail (Bhatt et al., 2012; Martinez et al., 2013) . Recently, a whole new spectrum of next-generation sequencing-based methods has evolved, enabling the characterization of the molecular features of transcriptional repression in macrophages at an unprecedented level (Hah et al., 2015; Kang et al., 2017) . IL-4-or IL-13-induced alternative macrophage polarization occurs in a number of pathological processes including nematode infection, tumor development, lung inflammation, and fibrosis (Gordon and Martinez, 2010) . Given the complex immunological milieu that characterizes each of these conditions, alternatively polarized macrophages are likely to encounter inflammatory stimuli as well (Fort et al., 2001; Ruffell et al., 2012) . It has been shown that in vitro modeling of complex immunological microenvironment by IL-4 and IFN-g co-stimulation leads to the attenuation of IFN-g-induced transcriptional activation due to the effects of IL-4 on restrictive set of auxiliary transcription factors in mouse macrophages (Piccolo et al., 2017) . These results suggest that alternatively polarized macrophages exhibit an altered responsiveness to inflammatory signals. The underlying crosstalk at the epigenomic and transcriptional levels remained largely unexplored. One of the effector functions of macrophages is the integration of different danger signals with NLRP3 inflammasome activation (Rathinam and Fitzgerald, 2016) . Inflammasomes play key roles in the generation of secreted forms of proinflammatory IL-1b and IL-18 from their precursors. In parallel, macrophages undergo active NLRP3 inflammasome-dependent cell death termed ''pyroptosis'' (Rathinam and Fitzgerald, 2016) . The integration of this process to inflammatory epigenomic signaling is also not known.
We sought to address these questions regarding the integration and regulation of the alternatively polarized macrophage phenotype by carrying out systemic genome-wide studies.
RESULTS

IL-4 Induces Transcriptional Activation and Repression via STAT6
We determined the STAT6-dependent IL-4-regulated genes in a time course in wild-type (WT) and Stat6 À/À bone marrow-derived macrophages (BMDMs) using RNA-seq ( Figure S1A ). First, we examined the gene expression pattern of the 1,614 IL-4-regulated genes (Fc R 2, p value < 0.05) and identified four IL-4-induced gene expression clusters based on expression dynamics and fold induction (Figures 1A and S1B; Table S1 ).
We also found that a high proportion of IL-4-responsive genes (39%) were repressed. Repression by IL-4 was observed after 3 hr and remained attenuated at later time points (6, 24 hr) ( Figure 1A , cluster E; Table S1 ). IL-4-mediated repression is dependent on STAT6 ( Figure 1B ). For validation, we measured the mRNA level of six Clec4d, Fos, Tlr2, Cd14, and Nlrp3) and three activated (Klf4, Hbegf, and Edn1) genes with RT-qPCR, and we confirmed the IL-4-mediated and STAT6-dependent regulation ( Figures 1C and S1C ). Filarial nematode infection is associated with the accumulation of alternatively polarized macrophages, exhibiting elevated expression of Ym1 and Fizz1/RELM-a (Anthony et al., 2006) . In order to determine whether transcriptional repression in response to alternative polarization signals occurs in vivo, we compared the gene expression profile of peritoneal macrophages from Brugia malayi nematode-implanted mice (Ne-Mac) and thioglycollate-elicited peritoneal macrophages (Thio-Mac) utilizing publicly available RNA-seq data (Thomas et al., 2012) . Gene set enrichment analysis (GSEA) showed that the in vitro IL-4-repressed gene set was significantly enriched (FDR q-value < 0.1, NER: À2.38) among the genes that were downregulated in response to nematode infection in peritoneal macrophages ( Figure 1D ). In addition, all selected IL-4-STAT6-repressed genes were significantly downregulated during Brugia malayi-induced in vivo alternative macrophage polarization compared to thioglycollateelicited peritoneal macrophages ( Figure 1E ).
Next, we determined whether IL-4-STAT6 signaling represses gene expression at the transcriptional or post-transcriptional level. We assessed the immediate early effect of IL-4 on two serine phosphorylated forms of RNA polymerase II (RNAPII), the active histone mark H3K27Ac using chromatin immunoprecipitation sequencing (ChIP-seq), and nascent RNA expression by Global Run-On sequencing (GRO-seq) after 1 hr of exposure. Elongation-specific RNAPII-pS2 ChIP-seq revealed 5,931 gene bodies, exhibiting significantly changing read enrichments (3,008 downregulated and 2,923 upregulated, p % 0.1) (Figure S2A and Table S2 ). RNAPII-pS2 binding showed positive correlation with transcription initiation-specific RNAPII-pS5 binding, H3K27Ac enrichment, and nascent RNA expression at the gene bodies ( Figure S2B ). Importantly, the gene bodies of IL-4-repressed genes (cluster E) showed attenuated RNAPII-pS2, RNAPII-pS5, and H3K27Ac enrichment and nascent RNA expression (Figures 2A, 2B , and S2C). In contrast, IL-4-dependent induction of RNAPII-pS2, RNAPII-pS5, and H3K27Ac enrichment as well as nascent RNA expression was detected at gene bodies of IL-4-induced genes (clusters A-C) (Figures 2A, S2C , and S2D). These results indicate that IL-4-STAT6 signaling directly represses gene expression, primarily at the transcriptional level during alternative macrophage polarization in vitro and in vivo.
IL-4-Activated STAT6 Binding Is Required for Transcriptional Repression
We also determined the STAT6 cistrome using a time course of 1, 6, and 24 hr of IL-4 stimulation ( Figure S1A ). STAT6 binding was negligible in unstimulated BMDMs ( Figure 3A ), but as little as 1 hr of stimulation dramatically induced the binding of STAT6, which was followed by a decline after 24 hr ( Figure 3A ). Comparing the STAT6 cistrome (20,119 genomic regions in IL-4-stimulated cells) to the RNAPII-pS5-positive genomic regions revealed that 60.5% of STAT6 peaks overlapped with the union of those genomic regions bound by RNAPII-pS5 in resting or IL-4-treated BMDMs ( Figure 3B ), suggesting that transcription could be directly regulated by STAT6 at these sites. Therefore, we next classified the RNAPII-pS5-positive STAT6 peaks based on IL-4-dependent regulation of RNAPII-pS5 binding, and we divided the STAT6-bound genomic regions into three different clusters: ''repressor,'' ''neutral,'' and ''activator'' STAT6 peak clusters ( Figure 3C and Table S3 ). We noted that repressor and neutral STAT6 peaks showed typically lower occupancies if compared to the IL-4-induced RNAPII-pS5-associated activator STAT6 peaks ( Figure S3A ). Interestingly, IL-4-dependent regulation of RNAPII-pS2 binding as well as H3K27Ac enrichments showed similar patterns to RNAPII-pS5 in all three STAT6 clusters ( Figures 3C and 3D ). These findings support the conclusion that IL-4-activated STAT6 can be associated with either transcriptional activation or repression at different genomic loci.
Next we assigned STAT6-bound genomic regions to genes in order to assess the correlation between IL-4-repressed enhancer activity (RNAPII-pS5 by ChIP-seq) and gene expression (mRNA by RNA-seq). For this analysis, we predicted the sub-topologically associated domains (subTADs) in which gene regulation by STAT6 might take place, using CTCF and RAD21 ChIP-seq datasets from BMDM, utilizing a previously described algorithm Rao et al., 2014) . As shown in Figure 3E , we found that repressor STAT6 peaks were tightly associated with the IL-4-repressed gene cluster (cluster E). In contrast, activator STAT6 peaks were associ- ated with the immediate early IL-4-induced genes represented by clusters A-C ( Figure 3E ). These results suggest a tight connection between STAT6-dependent regulation of enhancer activity and neighboring gene expression in the same genomic compartment or transcription unit. To understand the IL-4-STAT6 signalingmediated transcriptional regulation in more detail, we carried out analyses on individual genes and enhancers. For the selected repressed and activated genes, we identified at least one STAT6-bound enhancer showing reduced and induced H3K27 acetylation and RNAPII binding, respectively ( Figure 3F ). Enhancer RNA (eRNA) expression is a reliable marker of enhancer activity (Natoli and Andrau, 2012) . Therefore, we measured eRNA expression at the repressor and activator STAT6 peaks by RT-qPCR. The expression of eRNAs were regulated in a similar manner as the enrichment of RNAPII-pS5 and RNAPII-pS2 and changes of H3K27Ac levels at the repressor and activator STAT6 sites in WT BMDMs ( Figures 3F, 3G , and S3B). Importantly, IL-4-mediated regulation of eRNA expression was abolished in the absence of STAT6 at the examined enhancers (Figures 3G and S3B) . Taken together, these results show that IL-4-activated STAT6 is required for the transcriptional repression characterized by decreasing RNAPII binding, histone acetylation, and consequently enhancer activity.
STAT6 Binds to Repressed Sites in the Absence of a Canonical Binding Motif
In order to investigate whether the functional characteristics of STAT6 peaks (activator versus repressor) are influenced by their genomic localization and/or the DNA sequences they are associated with, we analyzed the genomic distribution of STAT6 peak clusters. We found only minor differences between the distinct STAT6 peak clusters regarding genomic localization ns. ***
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Hbegf_ +43Kb relative to genes (Table S4 ). The majority of STAT6 peaks were localized in intergenic and intronic regions in the genome in all three clusters, and only about 10% of STAT6 binding sites were detected in promoter-proximal regions (Table S4) . We also examined the enrichment of active histone mark H3K4m1 at the STAT6-bound genomic regions using a publicly available ChIP-seq dataset (Ostuni et al., 2013) . Although H3K4m1 enrichment was observed at more than 98% of STAT6-bound genomic regions, it was not influenced by IL-4 treatment (Table S4 , Figure S3C) . These findings suggest that STAT6 primarily binds enhancers and that the functional characteristics of different STAT6 peak clusters cannot be explained by their genomic localization relative to genes. Next, we carried out de novo motif enrichment analysis of the sequences under the STAT6 peaks. PU.1, TRE, RUNX, and C/EBP motifs were enriched under all three clusters ( Figure S3D ). However, the canonical STAT6 motif was significantly underrepresented under repressor and neutral STAT6 peaks if compared to the activator STAT6 peaks ( Figures 3H and S3D ). Plotting the motif scores for PU.1, TRE, RUNX, and C/EBP revealed no significant differences between the different STAT6 peak clusters ( Figure S3E ). In contrast, motif score for STAT6 was lower in the repressor and neutral STAT6 peak clusters compared to the activator STAT6 peak cluster ( Figure 3I ). Considering that the presence of STAT6 is needed for repression ( Figure 1B ), these findings raise the possibilities that STAT6 is bound without direct DNA contact or that it recognizes non-canonical STAT6-binding motifs at repressed enhancers.
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STAT6-Mediated Repression of Enhancer Activity Is
Accompanied by Decreased Chromatin Accessibility and Lineage-Determining Transcription Factor Binding We investigated whether chromatin accessibility is affected at the STAT6-bound genomic regions by performing Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) experiments. Our genome-wide analyses showed increased chromatin accessibility at the activator STAT6-bound sites ( Figure 4A ), while significant reduction was detected in chromatin accessibility at the repressor STAT6-bound genomic regions ( Figure 4A ). These results suggest that both STAT6-mediated enhancer activation and repression are associated with the modification of chromatin structure during alternative macrophage polarization.
Chromatin openness determines enhancer activity in different cell types (Shlyueva et al., 2014) . Moreover, binding of macrophage LDTFs, PU.1, JUNB, IRF8, and C/EBPa are associated with active enhancers in macrophages (Glass and Natoli, 2016) . In addition, their binding motifs were among the most enriched transcription factor motifs under STAT6 peaks (Figure S3D) . Therefore, we decided to determine whether IL-4-STAT6 signaling-mediated repression is associated with modified binding of LDTFs and examined their binding at repressed enhancers in the presence or absence of IL-4 using ChIP-seq. A high portion of the STAT6 cistrome overlapped with the examined LDTF cistromes except for JUNB, which showed moderated overlap (Table S4) . Intriguingly, PU.1, JUNB, and C/EBPa binding was significantly decreased, while IRF8 binding was not modulated at the repressed STAT6-bound genomic regions after 1 hr IL-4 treatment in BMDMs ( Figures 4B and S4A ). In contrast, all four LDTFs showed significantly elevated binding at the IL-4-activated enhancers following IL-4 stimulation (Figures 4B and S4A) . These findings suggest that IL-4-STAT6 signaling pathway modulates the binding of LDTFs at STAT6-activated and -repressed enhancers to opposite directions.
IL-4-STAT6 Signaling Pathway-Mediated Repression of Enhancers Is Characterized by an Altered p300:HDAC Ratio
The acetylation status and thus the activity of enhancers are tightly controlled by histone acetyltransferase (HAT) and histone deacetylase (HDAC) enzymes (Calo and Wysocka, 2013) . Therefore, we examined the binding of the histone acetyltransferase p300 as well as classical histone deacetylases, including HDAC1, 2, and 3 at the STAT6-bound genomic regions after 1 hr of IL-4 exposure by ChIP-seq. We found that the majority of STAT6-bound genomic regions were either pre-loaded by p300 and classical HDACs or recruited these factors upon IL-4 BMDMs (B-D, F, and G) were treated with IL-4 for 1 hr. Data in (A)-(D) are combined from two independent biological replicates. Changes in (D) were considered significant at p < 0.00001 using paired t test and an average fold change cut off value of R 1.15 was used between control and IL-4-treated samples. # means significant difference, n.s. indicates not significant change. Data in (F) are representative of two independent biological replicates. Data in (G) are representative of five individual animals per genotype from two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant change. Error bars represent mean ± SD.
stimulation (Table S4 ). The binding of p300 was significantly increased at STAT6-activated enhancers, but significantly reduced at STAT6-repressed enhancers upon IL-4 treatment ( Figure 4C ). Interestingly, genome-wide analysis of IL-4-modulated HDAC binding showed significantly enhanced HDAC1, 2, and 3 occupancy at STAT6-activated enhancers, while STAT6-repressed enhancers showed no effect to IL-4, but exhibited HDAC binding at the basal state ( Figure 4D ). Collectively, these results show that STAT6-repressed enhancers are bound by both HATs and HDACs at the steady state and that p300 binding is selectively reduced by IL-4, resulting in a changed equilibrium favoring HDAC activity.
The Presence of HDAC3 Is Required for IL-4-STAT6-Mediated Repression on a Subset of Genes Direct interactions between classical HDACs and STAT transcription factors have been observed previously in numerous cell types influencing STAT-mediated direct transcriptional regulation (Icardi et al., 2012; Nusinzon and Horvath, 2003) . In addition, HDAC3 has been shown to participate in the regulation of alternative macrophage polarization in vitro and in vivo (Mullican et al., 2011) . Thus, we hypothesized that HDAC3, which is present at repressed enhancers ( Figure 4D ), might also contribute to IL-4-STAT6-induced repression. Therefore, we decided to examine the role of HDAC3 using a dataset from Mullican et al. BMDMs were treated with IL-4 for 1 hr (A-D, F-H) or 24 hr (E, I, and J). Data (A-D, F, and H) are combined from two independent biological replicates. Changes (A-D and H) were considered significant at p < 0.00001 using paired t test and an average fold change cut off value of R 1.15 was used between control and IL-4-treated samples. # means significant difference, ns indicates not significant change. Data (I) represent the mean and SD of three independent biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ns, no significant difference. Error bars represent means ± SD. Data (J) represent the mean and SD of three independent biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ns, no significant difference. Error bars represent means ± SD.
(2011). Applying K-mean clustering method, we found 1,628 IL-4-repressed genes (p % 0.05) in WT BMDMs ( Figure S4B ) and identified an IL-4-repressed gene cluster (cluster III, 371 genes) that showed attenuated repression in Hdac3 fl/fl Lyz2 Cre BMDMs following IL-4 treatment ( Figures 4E and S4B) . Although the basal expression of these genes did not show major differences between WT and Hdac3 fl/fl Lyz2 Cre BMDMs, the IL-4-induced repression was partially or completely abolished in the absence of HDAC3 (Figures 4E and S4B ). In addition, enrichments of RNAPII-pS5 and RNAPII-S2 were reduced at these gene bodies after 1 hr of IL-4 treatment in WT BMDMs ( Figure 4F ). Interestingly, 325 STAT6-repressed enhancers were found within the subTADs of IL-4-HDAC3-repressed genes ( Figure 4G ). These enhancers were bound by HDAC3, but HDAC3 occupancy was not altered by IL-4 stimulation ( Figures 4G and 4H ). Our results indicate that HDAC3 is required for the IL-4-induced repression of a specific subset of genes. Due to the fact that HDAC3 is one of the key components of NCoR and SMRT corepressor complexes (Karagianni and Wong, 2007) , we decided to determine whether the NCoR-SMRT complex itself participates in IL-4-STAT6-HDAC3-mediated repression as well. First, we determined the occupancy of NCoR and SMRT at HDAC3-bound enhancers using ChIP-seq data generated by others (Barish et al., 2012) . We found that the IL-4-STAT6-HDAC3-repressed enhancer set was bound by both NCoR and SMRT in unstimulated BMDMs ( Figure 4G ). Next, we investigated the requirement of NCoR in the IL-4-STAT6-HDAC3-mediated repression using Ncor1 fl/fl Lyz2 Cre immortalized bone marrow-derived macrophages (iBMDMs). We selected four genes for this analysis (Fos, Lyz1, Lyz2, and Smad3) based on their IL-4-STAT6-HDAC3-dependent repression ( Figures 4I, S4C , and S4D) and due to the fact that their enhancers were bound by HDAC3, NCoR, and SMRT ( Figure S4C ). Gene expression analysis showed that Fos and Lyz1 were expressed at a significantly higher level in unstimulated iBMDMs in the absence of NCoR compared to WT iBMDMs, while the basal expression of Lyz2 and Smad3 were not affected by NCoR ( Figure 4J ). In addition, IL-4-mediated repression of these genes was diminished in Ncor1 fl/fl Lyz2 Cre iBMDMs ( Figures 4J   and S4E ). In contrast, the basal expression and IL-4-induced repression of HDAC3-independent genes were not affected by NCoR, except for Abca1 ( Figure S4F ). Taken together, our findings suggest that IL-4-activated STAT6 mediates transcriptional repression via the NCoR-HDAC3 complex at a subset of genes representing one of the molecular mechanisms for STAT6-dependent transcriptional repression.
IL-4-STAT6-Mediated Direct Transcriptional Repression Affects the LPS-Induced Inflammatory Program of Macrophages
Next we were wondering whether the repressive action of IL-4-STAT6 leaves its footprint on the epigenome and affects the subsequent response of the cells to other stimuli. Using KEGG pathway analysis, we identified 12 signaling pathways whose overrepresentation was specific to IL-4-repressed genes (Figure S5A ). NOD-like receptor signaling and Toll-like receptor signaling among the top hits, which are known to be two major regulators of the inflammatory response ( Figure S5A Figures  1A, 1B, S5C , and S5D). These results raised the possibility that IL-4 is able to modulate the subsequent inflammatory response of the macrophage epigenome via directly repressed enhancers following the dissociation of STAT6. In order to determine whether prior activation of IL-4-STAT6 signaling is able to influence the inflammatory program of macrophages, we performed RNA-seq as well as RNAPII-pS5-, RNAPII-pS2-, and p65-specific ChIP-seq experiments on IL-4-pretreated and LPS-activated BMDMs ( Figure 5A ). Our global transcriptome analysis identified 1,350 LPS-activated genes (p % 0.05) in BMDMs ( Figure 5B , Table S5 ). Intriguingly, 520 genes showed significantly attenuated (p % 0.05) LPS responsiveness following IL-4 pretreatment including the above examined Tlr2, Cd14, Clec4d, and Nlrp3 ( Figure 5B , Table S5 ). In addition, LPS-mediated induction of 686 genes was not influenced significantly by IL-4 pretreatment, while 144 genes showed significantly elevated LPS activation in IL-4-pretreated BMDMs (Figure 5B and Table S5 ), suggesting that the interaction between the two pathways is not a general interference or attenuation, but it takes place on selective genomic regions. Interestingly, 6 out of 12 IL-4-repressed signaling pathways were also significantly overrepresented among the genes that were less induced by LPS following IL-4 pretreatment, including NOD-like receptor and Toll-like receptor signaling pathways ( Figure S5E ). Next, we investigated whether IL-4-STAT6 signaling modulates LPSdependent activation of inflammatory genes at the transcriptional or post-transcriptional level. We examined the IL-4-and LPS-regulated binding of RNAPII-pS2 at the gene bodies of LPS-induced genes using ChIP-seq. RNAPII-pS2 binding showed a similar pattern to ''steady-state'' mRNA level in all three gene expression clusters, suggesting that IL-4 pretreatment modulates LPS-induced gene expression primarily at the transcriptional level ( Figure 5C ). In order to investigate whether the IL-4-attenuated inflammatory response is STAT6 dependent, we measured the expression of Tlr2, Cd14, Clec4d, and Nlrp3 in WT and Stat6 À/À BMDMs after 24 hr of IL-4 pretreatment followed by 3 hr of LPS activation. As expected, IL-4 pretreatment failed to inhibit the LPS response of these genes in the absence of STAT6 (Figure 5D ), raising the possibility that IL-4-activated STAT6 can directly modulate LPS responsiveness in macrophages via transcriptional repression of certain components of the inflammatory program.
To determine whether the crosstalk between IL-4-STAT6 signaling and inflammation-activated signaling pathways can also be observed at the enhancer level, we compared the IL-4-activated STAT6-and LPS-activated p65 cistromes in the subTADs of IL-4-attenuated LPS-responsive genes. 961 genomic regions were identified with overlapping STAT6 and p65 peaks revealing a partial overlap between the STAT6 and p65 cistromes ( Figures 6A and 6B) . Next, we decided to investigate whether IL-4-STAT6 and inflammatory signaling pathways are able to interact with each other using RNAPII-specific ChIP-seq analysis. 641 out of 961 genomic regions were associated with significantly elevated RNAPII-binding following LPS activation ( Figure 6B ). Intriguingly, 70% (448/641) of LPS-activated enhancers showed significantly reduced basal and LPS-induced RNAPII binding after 24 hr of IL-4 pretreatment ( Figures  6B-6E ). To further explore the mechanism of IL-4-STAT6-attenuated inflammatory responsiveness, we determined LPSinduced p65 binding at this enhancer set in IL-4-pretreated and unstimulated BMDMs. Based on p65 binding, we could identify two subsets of these enhancers including IL-4-insensitive and IL-4-attenuated p65 binding-associated enhancers (Figures 6E and 6F) . LPS-induced p65 binding was significantly reduced at 74 IL-4-repressed enhancers, while IL-4-repressed inflammatory response was not associated with modulated p65 binding at 374 enhancers (Figures 6E and 6F) . To investigate the STAT6 dependency of IL-4-repressed enhancer activity and p65 binding, we selected three enhancers for both analyses. RT-qPCR-based eRNA expression analysis confirmed IL-4-mediated and STAT6-dependent repression of basal and LPS-induced activity at the selected enhancers ( Figure S6A ). By performing ChIP-qPCR on the selected IL-4-reduced p65 binding-associated enhancers, we confirmed that IL-4-dependent reduction of LPS-induced p65 binding was completely abolished in the absence of STAT6 ( Figure S6B ). Taken together, these findings suggest that the activation of IL-4-STAT6 signaling is able to attenuate the inflammatory response of macrophages through selective, direct repression of a distinct LPS-activated enhancer set.
IL-4-Mediated Repression of Inflammatory Response
Results in Attenuated Inflammasome Activation, Decreased IL-1b Production, and Pyroptosis Genes showing antagonistic regulation by IL-4 and LPS were mostly associated with inflammation-associated pathways, including NOD-like and Toll-like receptor signaling ( Figure S5E ). It is known that NOD-like receptors are required for inflammasome activation leading to IL-1b secretion and inflammasomeassociated cell death, pyroptosis (Rathinam and Fitzgerald, 2016) . As shown above, IL-4-STAT6 was able to reduce the basal and LPS-induced expression of a key inflammasome component, Nlrp3 (Figures 1C and 5D ). Therefore, we investigated whether IL-4-STAT6 signaling is able to influence IL-1b production and pyroptosis. First, we examined the transcriptional regulation of Il1b expression in IL-4-pretreated and LPSactivated BMDMs. Reduced basal and LPS-induced RNAPIIpS2 and RNAPII-pS5 binding at Il1b gene body as well as Il1b mRNA expression were found in IL-4-pretreated BMDMs (Figures 7A and 7B) . Moreover, Il1b_À9.7Kb enhancer located within the predicted subTAD of Il1b showed antagonistic regulation by LPS and IL-4 ( Figure 7A ). Intriguingly, LPS-induced p65-binding at the STAT6-bound Il1b_À9.7Kb enhancer (in case of one out of two p65 peaks) was partially attenuated by IL-4-STAT6 signaling pathway similarly to Fcgr1_À7.7Kb and Il18_+25Kb enhancers described above (Figures 7A and 7C) . Accordingly, IL-4-dependent repression of basal and LPS-induced eRNA expression was observed at the Il1b_À9.7Kb enhancer ( Figure 7D ). The IL-4-dependent repression of basal and LPS-induced Il1b mRNA and eRNA expression were completely abolished in the absence of STAT6 (Figures 7B and 7D) . LPS-induced NLRP3 and pro-IL1b expression were also attenuated at the protein level by IL-4-STAT6 signaling ( Figures 7E and S7A) , while the expression of other inflammasome components including proCaspase-1 and ASC was not altered following IL-4 and LPS stimulation of BMDMs ( Figures 7E and S7A) .
In order to determine whether IL-4-dependent repression of Nlrp3 expression is associated with decreased inflammasome activity, we analyzed the LPS and ATP-induced Caspase-1 activity in IL-4-pretreated and unstimulated mouse BMDMs using laser scanning cytometry. As expected, Caspase-1 activation in WT BMDMs was induced dramatically by LPS and ATP costimulation ( Figure 7F ). Interestingly, LPS-and ATP-induced Caspase-1 activity was reduced significantly following 24 hr of IL-4 pretreatment, which was completely dependent on STAT6 (Figure 7F) . To assess the functional consequence of IL-4-STAT6-dependent reduction of inflammasome activation, we measured the secretion of IL-1b in the presence of LPS and ATP in IL-4-pretreated and untreated WT and Stat6 À/À BMDMs. IL-1b secretion was induced dramatically in WT and Stat6 À/À BMDMs following LPS treatment ( Figure 7G ). However, LPS-dependent induction of IL-1b secretion was partially inhibited by IL-4 pretreatment in a STAT6-dependent manner ( Figure 7G ). Next, we investigated the role of IL-4-STAT6 signaling pathway in inflammasome activation-induced macrophage cell death, pyroptosis. A hallmark of pyroptosis is the insertion of pores into the plasma membrane that can be detected via LDH activity measurement from BMDM supernatants and propidium iodide (PI) staining. IL-4 pretreatment was able to effectively inhibit both LPSinduced LDH release and PI uptake in WT, but not in Stat6
BMDMs ( Figures 7H and 7I ). Finally, we determined whether the inflammatory responsiveness of Nlrp3 and Il1b is influenced in vivo by nematode infection triggered alternative macrophage activation. Therefore, we infected mice with Heligmosomoides polygyrus (H. polygyrus) and injected LPS or Salmonella Typhimurium into the peritoneal cavity 9 days after nematode infection. As expected, the number of the M2 macrophage marker Ym1-positive macrophages was highly induced in peritoneal macrophages of H. polygyrus-infected mice, confirming alternative macrophage activation following nematode infection ( Figure S7B ; R€ uckerl et al., 2017) . In addition, inflammatory marker NOS2-positive macrophage number was dramatically elevated in control and H. polygyrusinfected mice following LPS injection or Salmonella Typhimurium infection, showing the emergence of infection ( Figure S7B ). Although Nlrp3 was not induced in the applied experimental system by LPS injection or Salmonella Typhimurium infection, steady-state expression was significantly inhibited by H. polygyrus infection, and the inhibitory effect of nematode infection was sustained in the presence of inflammatory stimuli ( Figure 7J ). Nematode infection did not result in Il1b expression by peritoneal macrophages but both LPS injection and Salmonella Typhimurium infection resulted in a robust induction of Il1b expression. This elevated expression was significantly diminished in macrophages from H. polygyrus-infected mice ( Figure 7J ).
These results suggest that prior in vitro or in vivo alternative macrophage polarization are able to restrain the subsequent inflammatory response of macrophages, including inflammasome activation and IL-1b secretion as well as pyroptosis due to direct repression of Nlrp3 and Il1b gene expression by IL-4-STAT6 signaling.
DISCUSSION
We unraveled an unsuspected repressor activity of the macrophage polarizing transcription factor, STAT6. We identified the (F) Genome browser views of the IL-4 repressed regulatory regions showing attenuated LPS response in IL-4-pretreated BMDMs. ChIP-seq signals for RNAPIIpS5, RNAPII-pS2, and p65 are shown. BMDMs were pretreated with IL-4 for 24 hr followed by 1 hr LPS exposure (A-E). Data (A-E) are combined from two independent biological replicates. Changes (D, E) were considered significant at p < 0.00001 using paired t test and an average fold change cut off value of R 1.15 was used between control and IL-4-treated samples. # means significant difference, ns indicates not significant difference. Data (F) are representative of two independent biological replicates. (legend continued on next page) target enhancers of repressor STAT6, as well as the major components of the repressive mechanisms and its biological consequences.
Macrophages exhibit great functional diversity and the ability to undergo rapid reprogramming depending on the changing molecular milieu in physiological and pathological conditions (Mosser and Edwards, 2008; R€ uckerl et al., 2017) . The epigenomic and molecular mechanisms of transcriptional activation by inflammatory mediators, cytokines, and lipids have been intensively studied in macrophages (for a review see Glass and Natoli, 2016) . In contrast, the mechanistic background of macrophage polarization signal-mediated transcriptional repression is less understood, though LPS-reduced nascent RNA expression was described (Bhatt et al., 2012) . In addition, LPS-and TNFadependent reduction of enhancer activity was also observed in macrophages and adipocytes in the absence of inflammationactivated NF-kB-p65 binding (Hah et al., 2015; Schmidt et al., 2015) . In contrast, we show that the IL-4-STAT6 signaling pathway represses a significant portion of macrophage transcriptome via STAT6-bound enhancers, providing evidence that direct transcriptional repression also occurs during alternative macrophage polarization.
Although the global transcriptional repressor activity of the key TFs for macrophage polarization (NF-kB, AP-1, and STATs) is not fully understood, several other SDTFs have been shown to possess distinct repressor activities. Ligand-activated nuclear receptors including PPARs and LXRs are able to reduce the activity of inflammatory SDTFs through transrepression carried out by direct protein-protein interactions without direct DNA binding (Glass and Saijo, 2010) . It has also been described that a specific NF-kB-binding motif is present in the promoter regions of tolerogenic inflammatory genes regulating LPS tolerance via recruitment of the p50-NCoR-HDAC3 repressosome (Yan et al., 2012) . Our findings show that repressed enhancers exhibit lower STAT6 occupancy and underrepresented STAT6 de novo motifs compared to activated enhancers. These observations suggest that STAT6 acts as a transcriptional repressor either (1) without direct DNA binding or (2) by recognizing non-canonical STAT6-binding motifs. It remains to be identified which mechanism is at play and, if STAT6 binding to the DNA is indirect, which DNA-bound factor interacts with STAT6. Our motif analysis suggests that the lineage-determining factors (PU.1 and C/EBPa) are the most likely candidates though PU.1 and C/EBPa binding also decreased at STAT6-repressed enhancers. Thus this requires further investigations.
STAT6-mediated repression appears to be distinct from other repressive mechanisms. Histone acetylation and gene expression tightly depends on the cofactor composition (HAT:HDAC ratio) (Calo and Wysocka, 2013) . Several findings show the extensive participation of co-repressor proteins and HDACs in the inhibition of transcriptional activation by cytokine-activated STAT proteins (Icardi et al., 2012) . However, the molecular mechanisms of STAT6-mediated direct transcriptional repression following IL-4 activation have not been described. Our cistromic studies show diminished p300 binding at STAT6-repressed enhancers in IL-4-exposed macrophages, suggesting that reduced p300 binding is likely to be a key mechanism in the IL-4-STAT6 signaling pathway-mediated transcriptional repression. In addition, STAT6-repressed enhancers were occupied by HDAC1, 2, and 3, though their binding was not altered following IL-4 stimulation. Nevertheless, our findings show evidence for the participation of NCoR-HDAC3 corepressor complex in the IL-4-STAT6-induced transcriptional repression in a distinct subset of IL-4-repressed genes. Our data suggest that either the changed equilibrium between HATs and HDACs or perhaps the activity of HDAC3 are regulated upon IL-4 stimulus. Potential mechanisms for the latter include posttranslational modifications and allosteric regulation. The mechanisms of non-HDAC3-dependent repression also remain to be identified.
Alternatively, polarized macrophages are required for effective protection against different nematode infections reducing parasite number and inhibiting nematode-induced tissue damage (Allen and Sutherland, 2014) . However, nematode infection-induced Th2 cell-type inflammation can also influence the immune response against other pathogens and the prevalence of autoimmune or inflammatory diseases (Elliott and Weinstock, 2012; R€ uckerl et al., 2017) . Therefore, a better understanding of the potential interactions between Th2 and Th1 cell-type inflammation-activated signaling pathways has a great importance in macrophage biology and also in immune-inflammatory pathologies. It has been recently published that the IL-4-STAT6 signaling pathway can partially suppress IFNg-induced transcriptional program in macrophages following IL-4 and INF-g co-treatment (Piccolo et al., 2017) . However, our findings provide evidence that IL-4-STAT6 signaling pathway induces epigenetic changes that persist following the release of STAT6 from the DNA, leading to attenuated activation of inflammatory enhancers. The consequence of IL-4 priming-induced repression of inflammatory enhancers is the decreased responsiveness to inflammatory signals via diminished basal and LPS-induced expression of several components of Toll-like and Nod-like receptor signaling pathways. In addition, the majority of IL-4-STAT6-repressed genes show diminished expression in macrophages derived from Brugia malayii-implanted mice compared to thioglycollate-elicited macrophages. This formally suggests that alternative polarization likely induces partial desensitization of macrophages to further inflammatory signals in vivo. Accordingly, M2-type macrophages have been shown to protect mice against chemically induced colitis and a growing body of evidence indicates that clinically controlled helminth infection is able to ameliorate inflammatory bowel disease (IBD) (Weinstock and Elliott, 2013) . These studies suggest that complex bidirectional interactions exist between different polarization signals that determine the overall sensitivity and responsiveness of macrophages toward environmental stimuli. Our findings provide insights into this cross-talk at the level of individual enhancers and raise the intriguing possibility that IL-4-STAT6 signaling, through direct transcriptional repression of inflammatory enhancers, induces desensitization of macrophages to microbial-, stress-, and damage-associated endogenous signals.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
Statistical analysis
Statistical analysis for qRT-PCR, ChIP-qPCR, ELISA, LDH-release assay, FACS analysis and densitometry analysis of western blot: the error bars represent standard deviation (SD). The two-tailed Student's t test was used to evaluate the significance of differences between two groups. Quantification and alignments of NGS analysis for RNA-seq, ChIP-seq and ATAC-seq are also described in more detail in the methods section above.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq, ChIP-seq, GRO-seq, and ATAC-seq data reported in this paper is GEO: GSE106706. Microarray and RNA-seq datasets were downloaded from NCBI GEO depository (GSE33609) and ArrayExpress (E-MTAB-995). ChIP-seq datasets were downloaded from NCBI GEO depository (GSE27060 and GSE38379) as well as Sequence Read Archive (SRP019970). The used genome-wide datasets are collected in Table S7 .
